Product Information
FLUOXETINE HCL 60 MG TABLET is a generic product labeled by Strides Pharma Inc., priced at $0.1817 per EA under NDC 64380090004. Its NADAC has been published 96 times since Dec 4, 2024.
FDA first approved this application on Sep 13, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
60 mg/1
Manufacturer
Strides Pharma Inc.NDC
64380090004
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
FLUOXETINEApproval Type
Generic (ANDA)
FDA Application
ANDA212683FDA Approved
9/13/2024
TE Code
AB
On Market Since
11/8/2024
Pharmacological Classes
Price Statistics
The NADAC for FLUOXETINE HCL 60 MG TABLET has been published 96 times since Dec 4, 2024, and over the history we have for it it has declined 43.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1817 per EA |
|---|---|
| All-time high | $0.4482 (Apr 16, 2025) |
| All-time low | $0.1817 (Sep 23, 2026) |
| 52-week high | $0.4087 |
| 52-week low | $0.1817 |
| Median price | $0.3610 |
| Average price | $0.3380 |
| Largest weekly change | -18.4% (May 20, 2026) |
| Weeks tracked | 96 |
| Tracking since | Dec 4, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the fluoxetine hcl market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Strides Pharma Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
fluoxetine hcl market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin Reuptake Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FLUOXETINE HCL 60 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FLUOXETINE HCL 60 MG TABLET, manufactured by Strides Pharma Inc., is $0.1817 per EA (NDC 64380090004), effective Sep 30, 2026.
How has the price of FLUOXETINE HCL 60 MG TABLET changed over time?
Over the history we have for it, the NADAC for FLUOXETINE HCL 60 MG TABLET has declined 43.2%. It has been tracked across 96 weekly CMS publications since Dec 4, 2024.
What are the highest and lowest recorded NADAC prices for FLUOXETINE HCL 60 MG TABLET?
Since Dec 4, 2024, the NADAC for FLUOXETINE HCL 60 MG TABLET has ranged from a low of $0.1817 (Sep 23, 2026) to a high of $0.4482 (Apr 16, 2025), with a median of $0.3610 per EA.
Are there cheaper alternatives to FLUOXETINE HCL 60 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of FLUOXETINE HCL 60 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures FLUOXETINE HCL 60 MG TABLET?
FLUOXETINE HCL 60 MG TABLET (NDC 64380090004) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.